EvoMed Webinar: "A new approach to Clinical Adoption"

On 3 March, from 5:00–6:00 PM CET, a dedicated webinar will explore how regulation in HealthTech can drive AI innovation while ensuring safety, compliance, and traceability.

 

The session will present a new approach to clinical adoption, focusing on how MedTech strategies break, and how these issues can be identified early, often well before they surface during clinical rollout or market entry. Through practical examples and regulatory insights, the webinar will illustrate how thoughtful regulatory alignment can serve as a catalyst for innovation rather than a barrier.

 

The webinar will be hosted and led by EvoMed Consulting’s CEO & Founder, Dr. Amel Havkic, who was recently awarded the Rising Star Award at MedTech World (Middle East). Drawing on his research into failed MedTech ventures and his experience advising health technology companies on regulatory and market strategy, Dr. Havkic will outline how early regulatory intelligence, risk anticipation, and structured governance frameworks can materially improve the probability of clinical and commercial success.

 

Designed for MedTech and HealthTech leaders, innovators, and strategists, the webinar aims to provide actionable perspectives on building AI-enabled solutions that are both clinically adoptable and regulatorily sound.'